Fundraising FoxCasdin Capital — 2025 Investments
4 investments dated 2025 · listed companies and verified rows first · show all
Deepcell uses artificial intelligence and high-resolution imaging to analyze cell morphology for biological research and discovery.
AI & Machine LearningBiotechDeep TechMedical DevicesSunnyvale, US
Mahdokht Masaeli(Executive Officer, Director, Promoter)Mahyar Salek(Executive Officer, Director, Promoter)inMaddison Masaeli(Founder)inEuan Ashley(Director, Promoter)
Co-investorsAndreessen HorowitzBow CapitalDCVC (Data Collective)Fifty YearsHorizons VenturesLifeX Ventures+3 more
Octant is a therapeutics company that develops small molecule drugs to treat protein misfolding diseases.
AI & Machine LearningBiotechDeep TechMedical DevicesEmeryville, US
Sri Kosuri(Founder)inRamsey Homsany(Founder)inRobert Andrade(Executive Officer, Director, Promoter)Maurice J. Costantini(Executive Officer, Director, Promoter)
Co-investorsAndreessen Horowitz+ND Capital8VCCarbon SiliconCatalio Capital Management, LPExplorer Investments+10 more
A pharmaceutical company developing therapeutics across oncology, hematology, neuroscience, immunology, and cardiovascular disease with a pipeline of 50 compounds targeting 40+ disease areas.
BiotechHealthtechMedical Devices
Co-investorsAndreessen HorowitzARCH Venture PartnersiGlobe PartnersAgent CapitalAlexandriaHeritage Medical Systems+5 more
Treeline develops therapeutics focused on oncology, leveraging insights from clinical practice and laboratory research.
AI & Machine LearningBiotechHealthtechMedical DevicesWatertown, US
Joshua H. Bilenker(Executive Officer, Director, Promoter)Jeffrey Engelman(Executive Officer, Director, Promoter)inJosh Bilenker(Founder)inJosh Bilenker Jeff Engelman(Founder)
BoardKristina Burow(Director)inAli Satvat(Director)
Co-investorsAisling CapitalARCH Venture PartnersGV (Google Ventures)OrbiMedARC VENTURESExor+3 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.